Peptide-based Immunotherapy

Peptide-Based Immunotherapy is a therapeutic strategy within antigen-specific immunotherapy that utilizes short, synthetic peptide fragments derived from target allergens or autoantigens to modulate immune responses by inducing tolerance or desensitization without eliciting adverse inflammatory reactions.

508

Publications

32.2K

Citations

3.3K

Authors

903

Institutions

Publications per year

2017–2026

99

Authors

3.3K

  1. AY
    Akira Yamada

    Kurume University, Japan

    16 publications · 684 citations

    15

    h-index

  2. KI
    Kyogo Itoh

    Kurume University, Japan

    14 publications · 625 citations

    13

    h-index

  3. ML
    Mark Larché

    McMaster University, Canada

    14 publications · 1.1K citations

    12

    h-index

  4. SS
    Stefan Stevanović

    University of Tübingen, Germany

    10 publications · 1K citations

    10

    h-index

  5. HR
    Hans‐Georg Rammensee

    University of Tübingen, Germany

    9 publications · 769 citations

    9

    h-index

1–5 of 3.3K

Venues

  1. The Journal of Immunology

    JI · 47 publications · 2.9K citations

    30

    h-index

  2. PubMed

    Repository · 30 publications · 1.6K citations

    19

    h-index

  3. Proceedings of the National Academy of Sciences

    PNAS · 17 publications · 2.2K citations

    16

    h-index

  4. Journal of Allergy and Clinical Immunology

    16 publications · 1.2K citations

    14

    h-index

  5. Cancer Immunology Immunotherapy

    11 publications · 460 citations

    11

    h-index

1–5